Other languages Nephros, Inc.

Equities

NEPH

US6406714005

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-18 pm EDT			5-day change	1st Jan Change
2.03 ^USD	+2.01%		+1.48%	-41.33%

Mar. 07	Transcript : Nephros, Inc., Q4 2023 Earnings Call, Mar 07, 2024
Mar. 07	Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07
Nephros, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08
Nephros, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Nephros, Inc. Announces Management Changes	23-05-08
Nephros, Inc. Announces CEO Changes	23-05-08
Nephros, Inc. Announces Preliminary Revenue Results for the First Quarter Ended March 31, 2023	23-04-04
Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-08
Nephros, Inc. and Donastar Enterprises Llc Announce Strategic Partnership	23-03-01
Nephros, Inc. Announces Board Changes	23-02-03
Nephros, Inc. Provides Revenue Guidance for the Fourth Quarter and Fiscal Year Ended December 31, 2022	23-01-11
Blue Water Solutions, Inc. completed the acquisition of Substantially all of Pathogen Detection Systems Business of Nephros, Inc..	22-11-14
Nephros, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2022	22-11-02
Nephros to Sell Pathogen Detection Systems Business	22-10-11
Nephros, Inc. Provides Revenue Guidance for the Quarter Ended September 30, 2022	22-10-11
Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation	22-09-28
Nephros Appoints Joe Harris to Its Board of Directors	22-09-08
Wes Lobo, Chief Commercial Officer of Nephros, Inc. Resigns, to Be Effective No Later Than September 30, 2022	22-08-23
Earnings Flash (NEPH) NEPHROS Reports Q2 Revenue $2.9M, vs. Street Est of $2.9M	22-08-10
Nephros, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2022	22-08-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Nephros, Inc.

Equities

NEPH

US6406714005

Other languages

Filters